Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide 400 mg/day for osteoarthritis of the knee
2006-005048-97Phase 2Terminated
- Sponsor
- Schwarz Pharma
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) comparing Lacosamide 400 mg/day with Placebo (2 arms). Started Dec 2006; status: terminated.
02
Drugs
lacosamide
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2006-005048-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005048-97.